GAMMA Investing »

Enliven Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.7k 66 25.55
2024-06-30 $1.1k 49 23.37
2024-03-31 $931 53 17.58
2023-12-31 $580 37 15.70